Fund moves
78 tracked managers disclosed the same change for Q1 2026. From a 13F filed May 1, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Apr 1, 2026 · Filed Apr 2, 2026
The CFO of Bristol Myers Squibb sold $1.57M of Bristol Myers Squibb shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$1,571,970
Shares × reported transaction price
55 days after results of Feb 5, 2026, 29 days before results of Apr 30, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $61.73 on Apr 1, 2026, within 2% of its 52-week high, after a 3% rise over the previous 30 trading days
52-week range $42.60 (Oct 29, 2025) to $62.37 (Feb 27, 2026), 97% of the way up, from 251 adjusted closes. 30 trading days earlier: $59.73 on Feb 18, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
FDA approved Opdivo on Mar 20, 2026, 12 days before this trade.
New use approved (efficacy supplement). Active ingredient: Nivolumab. From openFDA. Dates only; no link between the two is implied
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −2.1% | +4.1% | −6.3% |
| 30 days | −4.6% | +11.4% | −16.0% |
| 90 days | −4.4% | +14.0% | −18.4% |
| 180 days | −0.9% | +17.6% | −18.5% |
Past results only. Not a forecast.
Fund moves
78 tracked managers disclosed the same change for Q1 2026. From a 13F filed May 1, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
80 tracked managers disclosed the same change for Q1 2026. From a 13F filed Apr 30, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
78 tracked managers disclosed the same change for Q1 2026. From a 13F filed Apr 30, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.